Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-FR Version v7-EN
Language French English
Date Updated 2018-05-24 2018-01-08
Drug Identification Number 02330547 02330547
Brand name PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION
Common or Proper name PIPERACILLIN-TAZOBACTAM PIPERACILLIN-TAZOBACTAM
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients PIPERACILLIN TAZOBACTAM PIPERACILLIN TAZOBACTAM
Strength(s) 12G 1.5G 12G 1.5G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 VIAL 1 VIAL
ATC code J01CR J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date 2017-11-30 2017-11-30
Actual start date 2017-12-15 2017-12-15
Estimated end date 2018-05-11 2018-02-12
Actual end date 2018-05-04
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments